Brown Bob D 4
4 · Dicerna Pharmaceuticals Inc · Filed Nov 22, 2021
Insider Transaction Report
Form 4
Brown Bob
Chief Scientific Officer, SVP
Transactions
- Exercise/Conversion
Common Stock
2021-11-18$3.42/sh+24,936$85,281→ 25,203 total - Sale
Common Stock
2021-11-18$37.94/sh−24,936$946,072→ 267 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-18−24,936→ 0 totalExercise: $3.42Exp: 2023-09-24→ Common Stock (24,936 underlying)
Footnotes (3)
- [F1]The Reporting Person sold an aggregate of 24,936 shares of Common Stock on November 18, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 2.88% of 865,703 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2020.
- [F3]As of the transaction date, the option was fully vested. The option vested 1/48 monthly on the last day of each month with the vesting start date of 7/30/2013.